Skip to main content
Caplight Logo









NeuroHarmonics

NeuroHarmonics

Private
LondonHealthcare & Life Scienceshttps://neuroharmonics.com/

Last Round

Seed

Jan 22, 2026

Total Funding Raised

$2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeuroHarmonics is a deeptech company developing a non-invasive neurotechnology platform that uses ultrasound-based brain modulation to treat neurological and psychiatric conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

neuromodulationultrasound neuromodulationtranscranial ultrasounddeep brain stimulationDBSnon-invasive brain stimulationmedical devicebrain-computer interfaceBCIneurotechwearable medical devicetherapeutic ultrasoundneurological disorder treatmentbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroHarmonics Comparables

Compare NeuroHarmonics with similar companies based on industry and business-model similarity.

NeuroHarmonics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SPIRE Therapeutics, Inc.
89%
Grey Matter Neurosciences
87%
Attune Neurosciences
84%

NeuroHarmonics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 22, 2026

NeuroHarmonics Investors

Notable investors and investment history

NeuroHarmonics investors
InvestorRounds
Fusion FundSeed
EPSRCGrant
SpeedinvestSeed
Jumpspace VenturesSeed
Albion CapitalSeed
Wellcome TrustGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    $2M raised from Albion Capital and Fusion Fund.

  • Sep 4, 2025

    Grew 67% QoQ from 6 to 10 employees.

NeuroHarmonics Filings

Explore SEC and related filing metadata, where available.

NeuroHarmonics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroHarmonics's valuation, stock price, and market status.

Is NeuroHarmonics a public or private company?

NeuroHarmonics is a private company.

What is the current stock price of NeuroHarmonics?

NeuroHarmonics is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroHarmonics worth (valuation)?

Valuation information for NeuroHarmonics is not publicly available.

Can I buy NeuroHarmonics stock?

NeuroHarmonics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroHarmonics's last funding round?

NeuroHarmonics's most recent funding round was Seed on January 22, 2026.

Who are the main investors in NeuroHarmonics?

Key investors in NeuroHarmonics include Fusion Fund, EPSRC, Speedinvest, Jumpspace Ventures, Albion Capital.

Will NeuroHarmonics IPO soon?

No public IPO plans have been announced for NeuroHarmonics.

How can I track NeuroHarmonics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroHarmonics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2024
Last FundingJan 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?